Cargando…

Reversible blindness after erroneous prescription of closantel: A case report

A 20‐year‐old girl was referred with vision loss upon closantel use. Plasma exchange and high‐dose corticosteroid pulse therapy were administered. A 2.5‐year follow‐up showed improved vision and increased layer thickness of the peripheral nerve fiber. Early treatment with plasma exchange and high‐do...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheraghmakani, Hamed, Jafari, Reza, Karimpour‐razkenari, Elahe, Ghazaeian, Monireh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659543/
https://www.ncbi.nlm.nih.gov/pubmed/34938546
http://dx.doi.org/10.1002/ccr3.5157
_version_ 1784612987963703296
author Cheraghmakani, Hamed
Jafari, Reza
Karimpour‐razkenari, Elahe
Ghazaeian, Monireh
author_facet Cheraghmakani, Hamed
Jafari, Reza
Karimpour‐razkenari, Elahe
Ghazaeian, Monireh
author_sort Cheraghmakani, Hamed
collection PubMed
description A 20‐year‐old girl was referred with vision loss upon closantel use. Plasma exchange and high‐dose corticosteroid pulse therapy were administered. A 2.5‐year follow‐up showed improved vision and increased layer thickness of the peripheral nerve fiber. Early treatment with plasma exchange and high‐dose corticosteroid therapy can be beneficial to reverse closantel toxicity.
format Online
Article
Text
id pubmed-8659543
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-86595432021-12-21 Reversible blindness after erroneous prescription of closantel: A case report Cheraghmakani, Hamed Jafari, Reza Karimpour‐razkenari, Elahe Ghazaeian, Monireh Clin Case Rep Case Report A 20‐year‐old girl was referred with vision loss upon closantel use. Plasma exchange and high‐dose corticosteroid pulse therapy were administered. A 2.5‐year follow‐up showed improved vision and increased layer thickness of the peripheral nerve fiber. Early treatment with plasma exchange and high‐dose corticosteroid therapy can be beneficial to reverse closantel toxicity. John Wiley and Sons Inc. 2021-12-09 /pmc/articles/PMC8659543/ /pubmed/34938546 http://dx.doi.org/10.1002/ccr3.5157 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Report
Cheraghmakani, Hamed
Jafari, Reza
Karimpour‐razkenari, Elahe
Ghazaeian, Monireh
Reversible blindness after erroneous prescription of closantel: A case report
title Reversible blindness after erroneous prescription of closantel: A case report
title_full Reversible blindness after erroneous prescription of closantel: A case report
title_fullStr Reversible blindness after erroneous prescription of closantel: A case report
title_full_unstemmed Reversible blindness after erroneous prescription of closantel: A case report
title_short Reversible blindness after erroneous prescription of closantel: A case report
title_sort reversible blindness after erroneous prescription of closantel: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659543/
https://www.ncbi.nlm.nih.gov/pubmed/34938546
http://dx.doi.org/10.1002/ccr3.5157
work_keys_str_mv AT cheraghmakanihamed reversibleblindnessaftererroneousprescriptionofclosantelacasereport
AT jafarireza reversibleblindnessaftererroneousprescriptionofclosantelacasereport
AT karimpourrazkenarielahe reversibleblindnessaftererroneousprescriptionofclosantelacasereport
AT ghazaeianmonireh reversibleblindnessaftererroneousprescriptionofclosantelacasereport